SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010099
Filing Date
2019-11-06
Accepted
2019-11-06 11:55:10
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adap-20190930x10q8d3831.htm   iXBRL 10-Q 2051845
2 EX-10.1 ex-10d1.htm EX-10.1 167011
3 EX-10.2 ex-10d2.htm EX-10.2 174779
4 EX-31.1 ex-31d1.htm EX-31.1 11040
5 EX-31.2 ex-31d2.htm EX-31.2 11825
6 EX-32.1 ex-32d1.htm EX-32.1 6827
7 EX-32.2 ex-32d2.htm EX-32.2 6843
8 GRAPHIC ex-10d1g001.jpg GRAPHIC 6238
  Complete submission text file 0001558370-19-010099.txt   6686325

Data Files

Seq Description Document Type Size
9 EX-101.SCH adap-20190930.xsd EX-101.SCH 38205
10 EX-101.CAL adap-20190930_cal.xml EX-101.CAL 58262
11 EX-101.DEF adap-20190930_def.xml EX-101.DEF 85325
12 EX-101.LAB adap-20190930_lab.xml EX-101.LAB 332242
13 EX-101.PRE adap-20190930_pre.xml EX-101.PRE 242071
69 EXTRACTED XBRL INSTANCE DOCUMENT adap-20190930x10q8d3831_htm.xml XML 1063208
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 191195579
SIC: 2836 Biological Products, (No Diagnostic Substances)